Abstract
Within six hours of suspected acute myocardial infarction, 791 patients entered a randomised double blind study of combined intravenous and oral tocainide for the prophylaxis of primary ventricular fibrillation. Acute myocardial infarction was confirmed in 559 patients, of whom 278 had received tocainide. The study was terminated on the basis of a sequential statistical analysis which showed that in these patients tocainide was unlikely to reduce the incidence of primary ventricular fibrillation by as much as 50%, primary ventricular fibrillation having occurred in 4% of the tocainide and 2% of the placebo patients. Significantly fewer tocainide treated patients were withdrawn for other serious ventricular arrhythmias. Mortality (1% in the tocainide group and 2% in the placebo group) was low with no statistically significant differences between the active and placebo groups. Unwanted effects of treatment were infrequent and rarely troublesome both in patients with and without acute myocardial infarction. These results suggest that in the dosage used in this study tocainide does not exert an antifibrillatory action in the early phase of acute myocardial infarction.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. L., Mason J. W., Winkle R. A., Meffin P. J., Fowles R. E., Peters L., Harrison D. C. Clinical electrophysiologic effects of tocainide. Circulation. 1978 Apr;57(4):685–691. doi: 10.1161/01.cir.57.4.685. [DOI] [PubMed] [Google Scholar]
- Campbell R. W., Achuff S. C., Pottage A., Murray A., Prescott L. F., Julian D. G. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction. J Cardiovasc Pharmacol. 1979 Jan-Feb;1(1):43–52. doi: 10.1097/00005344-197901000-00005. [DOI] [PubMed] [Google Scholar]
- Graffner C., Conradson T. B., Hofvendahl S., Rydén L. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clin Pharmacol Ther. 1980 Jan;27(1):64–71. doi: 10.1038/clpt.1980.10. [DOI] [PubMed] [Google Scholar]
- Jones D. T., Kostuk W. J., Gunton R. W. Prophylactic quinidine for the prevention of arrhythmias after acute myocardial infarction. Am J Cardiol. 1974 May 6;33(5):655–660. doi: 10.1016/0002-9149(74)90258-6. [DOI] [PubMed] [Google Scholar]
- Koch-Weser J., Klein S. W., Foo-Canto L. L., Kastor J. A., DeSanctis R. W. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. N Engl J Med. 1969 Dec 4;281(23):1253–1260. doi: 10.1056/NEJM196912042812301. [DOI] [PubMed] [Google Scholar]
- Lie K. I., Liem K. L., Louridtz W. J., Janse M. J., Willebrands A. F., Durrer D. Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am J Cardiol. 1978 Sep;42(3):486–488. doi: 10.1016/0002-9149(78)90945-1. [DOI] [PubMed] [Google Scholar]
- Lie K. I., Wellens H. J., van Capelle F. J., Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974 Dec 19;291(25):1324–1326. doi: 10.1056/NEJM197412192912504. [DOI] [PubMed] [Google Scholar]
- Moore E. N., Spear J. F., Horowitz L. N., Feldman H. S., Moller R. A. Electrophysiologic properties of a new antiarrhythmic drug--tocainide. Am J Cardiol. 1978 Apr;41(4):703–709. doi: 10.1016/0002-9149(78)90821-4. [DOI] [PubMed] [Google Scholar]
- Rydén L., Arnman K., Conradson T. B., Hofvendahl S., Mortensen O., Smedgård P. Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction. Am Heart J. 1980 Dec;100(6 Pt 2):1006–1012. doi: 10.1016/0002-8703(80)90205-7. [DOI] [PubMed] [Google Scholar]
- Young M. D., Hadidian Z., Horn H. R., Johnson J. L., Vassallo H. G. Treatment of ventricular arrhythmias with oral tocainide. Am Heart J. 1980 Dec;100(6 Pt 2):1041–1045. doi: 10.1016/0002-8703(80)90211-2. [DOI] [PubMed] [Google Scholar]